Rebuilding Meaningful Healthcare Provider Relationships
BIO's newest article for PharmaTimes on why creating meaningful patient engagement experiences will be the engine for growth for big pharma brands.
Our Head of Strategy Stu Whyte and Head of CX Veronica Naguib build a detailed picture of the impact that the changing healthcare and pharma landscape have had on all audiences at play. They also explore the potential scenarios to carve out a more transparent and visible connection, not just between Pharma brands and doctors, but their patients as well.
Five key takeaways:
The current course of digital engagement tools provided by the main Pharma players don’t go far enough to provide tangible value;
The patient landscape is changing: our recent survey shows 59% of patients believe that Pharmas care more about their profits than their patients;
The HCP engagement gap: HCPs are being stretched beyond capacity, yet Pharmas don’t provide them with credible tools they can trust and learn from;
We discuss four trust building pillars: 1) Reliability through contextual content; 2) Efficiency through responsive data; 3) Accountability through complementary support; and 4) Responsiveness through cyclical communication;
We also propose a new enhanced information ecosystem model and describe why creating meaningful patient engagement experiences will be the engine for growth for big Pharma brands.
Read the full article: